美國整形外科之生物材料市場：2010年

本報告已在2012年05月09日停止出版。

更改為出版

U.S. Market for Orthopedic Biomaterials 2012

出版日期 : 2012年05月

商品編碼: 239911

簡介

美國整形外科的生物材料市場，於2009年達到35億美金之規模。預計該市場至2016年將以8.9%的年平均成長率持續擴大發展。

針對美國整形外科的生物材料市場，本報告書按照產品類別進行調查分析，書中彙整了市場預測、促進與阻礙發展之因素，以及競爭動態與新興技術等，內容概要摘記如下。

第1章 摘要

第2章 調查方法

第3章 整形外科專用的生物材料概要

• 導論
• 市場預測與分析
• 促進與阻礙發展之因素
• 競爭分析
• M&A

第4章 生長因子市場

• 導論
• 市場預測與分析
• 促進與阻礙發展之因素
• 競爭分析

第5章 人工代用骨市場

• 導論
• 市場區隔
• 市場預測與分析
• 人工代用骨市場的各種適應症
• 人工代用骨市場的各種材料
• 促進與阻礙發展之因素
• 競爭分析

第6章 加工骨同種異體移植市場

• 導論
• 市場預測與分析
• 促進與阻礙發展之因素
• 競爭分析

第7章 注射玻尿酸以治療關節炎的黏稠補充療法（viscosupplementation）市場

• 導論
• 市場預測與分析
• 促進與阻礙發展之因素
• 競爭分析

第8章 可吸收式顱骨內固定儀器

• 導論
• 市場預測與分析
• 促進與阻礙發展之因素
• 競爭分析

第9章 肌腱移植市場

• 導論
• 市場預測與分析
• 促進與阻礙發展之因素
• 競爭分析

第10章 軟骨修復市場

• 導論
• 市場預測與分析
• 促進與阻礙發展之因素
• 競爭分析

第11章 血小板、骨髓凝結市場

• 導論
• 市場預測與分析
• 促進與阻礙發展之因素
• 競爭分析

第12章 整形外科的幹細胞市場

• 導論
• 市場概要
• 市場預測與分析
• 促進與阻礙發展之因素
• 競爭分析

第13章 新興技術

• 導論

縮寫字

圖表

目錄

Abstract

In 2009, the orthopedic biomaterials market was valued at almost $3.5 billion. This market is expected to grow at a CAGR of 8.9% by 2016. The total orthopedic biomaterials market has experienced growth, despite the economic downturn, which began in 2008. The market started to spike in 2009 and peaked in 2010 largely driven by rapid growth in the stem cell, hyaluronic acid and synthetic bone graft substitute market segments.

This comprehensive report critically examines the following market segments:

• Bone graft substitutes
• Cartilage repair
• Growth factors
• Hyaluronic acid
• Machined allografts
• Resorbable fixation
• Stem cells
• Tendon grafts
• Platelet rich plasma
• Bone marrow concentration systems

Within the U.S. orthopedic biomaterials market, companies such as Arthrex, DePuy, Genzyme, Medtronic, Synthes and Smith & Nephew lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

Table of Contents

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

• 1.1 TOTAL ORTHOPEDIC BIOMATERIALS MARKET
• 1.2 GROWTH FACTOR AND BONE GRAFT SUBSTITUTE MARKET
• 1.3 MACHINED BONE ALLOGRAFT MARKET
• 1.4 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
• 1.5 RESORBABLE FIXATION DEVICE MARKET
• 1.6 TENDON GRAFT MARKET
• 1.7 CARTILAGE REPAIR MARKET
• 1.8 PLATELET AND BONE MARROW CONCENTRATION MARKET
• 1.9 STEM CELL MARKET
• 1.10 LEADING COMPETITORS

RESEARCH METHODOLOGY

• 2.1 RESEARCH SCOPE
• 2.2 IDATA' S 9-STEP METHODOLOGY
  • 2.2.1 Step 1: Project Initiation & Team Selection
  • 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
  • 2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
  • 2.2.4 Step 4: Performing Primary Research
  • 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
  • 2.2.6 Step 6: Market Forecast and Analysis
  • 2.2.7 Step 7: Identify Strategic Opportunities
  • 2.2.8 Step 8: Final Review and Market Release
  • 2.2.9 Step 9: Customer Feedback and Market Monitoring

OVERVIEW OF ORTHOPEDIC BIOMATERIALS

• 3.1 INTRODUCTION
  • 3.1.1 Growth Factors
  • 3.1.2 Bone Graft Substitutes
  • 3.1.3 Machined Bone Allografts
  • 3.1.4 Hyaluronic Acid Viscosupplementation
  • 3.1.5 Resorbable Fixation Devices
  • 3.1.6 Tendon Grafts
  • 3.1.7 Cartilage Repair
  • 3.1.8 Platelet and Bone Marrow Concentration
  • 3.1.9 Orthopedic Stem Cell Therapy
• 3.2 MARKET ANALYSIS AND FORECAST
• 3.3 MARKET DRIVERS AND LIMITERS
  • 3.3.1 Market Drivers
  • 3.3.2 Market Limiters
• 3.4 COMPETITIVE ANALYSIS
  • 3.4.1 Market Concentration
• 3.5 MERGERS AND ACQUISITIONS

GROWTH FACTOR MARKET

• 4.1 INTRODUCTION
  • 4.1.1 Overview
  • 4.1.2 BMP-2 (Medtronic)
  • 4.1.3 BMP-7 (Stryker)
  • 4.1.4 Potential Complications
  • 4.1.5 Reimbursement
  • 4.1.6 Future Indications
• 4.2 MARKET ANALYSIS AND FORECAST
• 4.3 MARKET DRIVERS AND LIMITERS
  • 4.3.1 Market Drivers
  • 4.3.2 Market Limiters
• 4.4 COMPETITIVE ANALYSIS
  • 4.4.1 Leading Competitors
  • 4.4.2 Potential Competitors

BONE GRAFT SUBSTITUTE MARKET

• 5.1 INTRODUCTION
• 5.2 MARKET SEGMENTATION
  • 5.2.1 Indications
  • 5.2.2 Materials
• 5.3 MARKET ANALYSIS AND FORECAST
• 5.4 BONE GRAFT SUBSTITUTE MARKET BY INDICATION
  • 5.4.1 Thoracolumbar Spinal Fixation Procedures
  • 5.4.2 Thoracolumbar Spinal Bone Graft Substitute Market
  • 5.4.3 Cervical Spinal Bone Graft Substitute Market
  • 5.4.4 Trauma Bone Graft Substitute Market
  • 5.4.5 Hip Bone Graft Substitute Market
  • 5.4.6 Knee Bone Graft Substitute Market
  • 5.4.7 Craniomaxillofacial Bone Graft Substitute Market
• 5.5 BONE GRAFT SUBSTITUTE MARKET BY MATERIAL
  • 5.5.1 Autograft
  • 5.5.2 Total Standard Allograft
  • 5.5.3 Total DBM Market
  • 5.5.4 Total Synthetic Bone Graft Substitute Market
• 5.6 MARKET DRIVERS AND LIMITERS
  • 5.6.1 Market Drivers
  • 5.6.2 Market Limiters
• 5.7 COMPETITIVE ANALYSIS
  • 5.7.1 Total Bone Graft Substitute Market
  • 5.7.2 Standard Allograft Market
  • 5.7.3 DBM Market
  • 5.7.4 Synthetic Bone Graft Substitute Market
  • 5.7.5 Autograft Market

MACHINED BONE ALLOGRAFT MARKET

• 6.1 INTRODUCTION
  • 6.1.1 Approaches
  • 6.1.2 Interbody Device Procedure Percentages by Material
• 6.2 MARKET FORECAST AND ANALYSIS
  • 6.2.1 ALIF Approach
  • 6.2.2 PLIF Approach
  • 6.2.3 TLIF Approach
  • 6.2.4 Cervical Machined Bone Allografts
• 6.3 MARKET DRIVERS AND LIMITERS
  • 6.3.1 Market Drivers
  • 6.3.2 Market Limiters
• 6.4 COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

• 7.1 INTRODUCTION
  • 7.1.1 Benefits of Viscosupplementation
  • 7.1.2 Synovial Fluid
  • 7.1.3 Three-Injection Cycle Products
  • 7.1.4 Five-Injection Cycle Products
  • 7.1.5 Single-Injection Cycle Products
  • 7.1.6 Reimbursement
• 7.2 MARKET ANALYSIS AND FORECAST
  • 7.2.1 Three-Injection Cycle
  • 7.2.2 Five-Injection Cycle Viscosupplementation Market
  • 7.2.3 Single-Injection Cycle Viscosupplementation Market
• 7.3 MARKET DRIVERS AND LIMITERS
  • 7.3.1 Market Drivers
  • 7.3.2 Market Limiters
• 7.4 COMPETITIVE ANALYSIS

RESORBABLE FIXATION DEVICE MARKET

• 8.1 INTRODUCTION
  • 8.1.1 Materials
  • 8.1.2 Disadvantages Compared to Metal Fixation
  • 8.1.3 Indications and Product Descriptions
• 8.2 MARKET ANALYSIS AND FORECAST
  • 8.2.1 Total Resorbable Fixation Market
  • 8.2.2 Shoulder Resorbable Fixation Market
  • 8.2.3 Knee Resorbable Fixation Market
  • 8.2.4 Meniscal Resorbable Fixation Market
• 8.3 MARKET DRIVERS AND LIMITERS
  • 8.3.1 Market Drivers
  • 8.3.2 Market Limiters
• 8.4 COMPETITIVE ANALYSIS
  • 8.4.1 Leading Competitors
  • 8.4.2 Other Notable Competitors

TENDON GRAFT MARKET

• 9.1 INTRODUCTION
  • 9.1.1 ACL/PCL Reconstruction Procedures
  • 9.1.2 Bone-Patellar Tendon-Bone (BTB) Graft, ACL/PCL Surgery
  • 9.1.3 Allograft Tendons
  • 9.1.4 Popularity of the Anterior Tibialis Autograft
  • 9.1.5 Ligament and Tendon Synthetic Grafts
  • 9.1.6 Ligament and Tendon Xenografts
• 9.2 MARKET FORECAST AND ANALYSIS
  • 9.2.1 Total Tendon Graft Market
  • 9.2.2 Analysis of Tendon Units Procured per Donor
• 9.3 MARKET DRIVERS AND LIMITERS
  • 9.3.1 Market Drivers
  • 9.3.2 Market Limiters
• 9.4 COMPETITIVE ANALYSIS

CARTILAGE REPAIR MARKET

• 10.1 INTRODUCTION
  • 10.1.1 Methods for Cartilage Repair
• 10.2 MARKET ANALYSIS AND FORECAST
  • 10.2.1 Cartilage Autograft Procedures
  • 10.2.2 Total Cartilage Repair Market
  • 10.2.3 Autologous Chondrocyte Implantation Market
  • 10.2.4 Osteochondral Allograft Market
  • 10.2.5 Meniscal Graft Market
• 10.3 MARKET DRIVERS AND LIMITERS
  • 10.3.1 Market Drivers
  • 10.3.2 Market Limiters
• 10.4 COMPETITIVE ANALYSIS
  • 10.4.1 Leading Competitors
  • 10.4.2 Emerging Competitors

PLATELET AND BONE MARROW CONCENTRATION MARKET

• 11.1 INTRODUCTION
  • 11.1.1 Platelet Rich Plasma
  • 11.1.2 Bone Marrow Aspirate
• 11.2 MARKET ANALYSIS AND FORECAST
  • 11.2.1 Total Platelet and Bone Marrow Concentration Market
  • 11.2.2 Spinal Platelet Concentration Market
  • 11.2.3 Extremity and Sports Medicine Platelet Concentration Market
  • 11.2.4 Bone Marrow Aspirate Concentration Market
• 11.3 MARKET DRIVERS AND LIMITERS
  • 11.3.1 Market Drivers
  • 11.3.2 Market Limiters
• 11.4 COMPETITIVE ANALYSIS
  • 11.4.1 Leading Competitors
  • 11.4.2 Other Competitors

ORTHOPEDIC STEM CELL MARKET

• 12.1 INTRODUCTION
• 12.2 MARKET OVERVIEW
  • 12.2.1 Lineage
  • 12.2.2 Legislation
  • 12.2.3 Other Therapeutic Applications
• 12.3 MARKET ANALYSIS AND FORECAST
  • 12.3.1 Lumbar Spine Stem Cell Market
  • 12.3.2 Cervical Spine Stem Cell Market
• 12.4 MARKET DRIVERS AND LIMITERS
  • 12.4.1 Market Drivers
  • 12.4.2 Market Limiters
• 12.5 COMPETITIVE ANALYSIS
  • 12.5.1 Leading Competitors
  • 12.5.2 Potential Competitors

EMERGING TECHNOLOGIES

• 13.1 INTRODUCTION
  • 13.1.1 Emerging Cartilage Repair Technologies
  • 13.1.2 Emerging Bone Graft Substitute Technologies
  • 13.1.3 Xenografts

ABBREVIATIONS

LIST OF FIGURES

EXECUTIVE SUMMARY

RESEARCH METHODOLOGY

OVERVIEW OF ORTHOPEDIC BIOMATERIALS

• Figure 3-1: Total Orthopedic Biomaterials Market, U.S., 2006 - 2016
• Figure 3-2: Drivers and Limiters, Orthopedic Biomaterials Market, U.S., 2009
• Figure 3-3: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2009 (Part 1 of 2)
• Figure 3-4: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2009 (Part 2 of 2)
• Figure 3-5: Market Concentration, Orthopedic Biomaterials Market, U.S., 2009

GROWTH FACTOR MARKET

• Figure 4-1: Total Growth Factor Market, U.S., 2006 - 2016
• Figure 4-2: Drivers and Limiters, Growth Factor Market, U.S., 2009
• Figure 4-3: Leading Competitors, Growth Factor Market, U.S., 2009

BONE GRAFT SUBSTITUTE MARKET

• Figure 5-1: Total Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-2: Thoracolumbar Spinal Fixation Procedures Segmented by Indication, U.S., 2006 - 2016
• Figure 5-3: Degenerative Thoracolumbar Spinal Fixation Procedures Segmented by Levels Fused, U.S., 2006 - 2016
• Figure 5-4: Thoracolumbar Spinal Bone Graft Substitute Market, U.S., 2006 2016
• Figure 5-5: Cervical Spinal Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-6: Trauma Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-7: Hip Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-8: Knee Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-9: CMF Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-10: Spinal Bone Graft Substitute Procedures, U.S., 2006 - 2016
• Figure 5-11: Total Standard Allograft Market, U.S., 2006 - 2016
• Figure 5-12: Spinal Standard Allograft Market, U.S., 2006 - 2016
• Figure 5-13: Thoracolumbar Spinal Standard Allograft Market, U.S., 2006 - 2016
• Figure 5-14: Cervical Spinal Standard Allograft Market, U.S., 2006 - 2016
• Figure 5-15: Trauma, Reconstruction and CMF Standard Allograft Market, U.S., 2006 - 2016
• Figure 5-16: Trauma Standard Allograft Market, U.S., 2006 - 2016
• Figure 5-17: Hip Reconstruction Standard Allograft Market, U.S., 2006 - 2016
• Figure 5-18: Knee Reconstruction Standard Allograft Market, U.S., 2006 - 2016
• Figure 5-19: CMF Standard Allograft Market, U.S., 2006 - 2016
• Figure 5-20: Total DBM Market, U.S., 2006 - 2016
• Figure 5-21: Spinal DBM Market, U.S., 2006 - 2016
• Figure 5-22: Thoracolumbar Spinal DBM Market, U.S., 2006 - 2016
• Figure 5-23: Cervical Spinal DBM Market, U.S., 2006 - 2016
• Figure 5-24: Trauma, Reconstruction and CMF DBM Market, U.S., 2006 - 2016
• Figure 5-25: Trauma DBM Market, U.S., 2006 - 2016
• Figure 5-26: Hip Reconstruction DBM Market, U.S., 2006 - 2016
• Figure 5-27: Knee Reconstruction DBM Market, U.S., 2006 - 2016
• Figure 5-28: CMF DBM Market, U.S., 2006 - 2016
• Figure 5-29: Total Synthetic Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-30: Spinal Synthetic Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-31: Thoracolumbar Spinal Synthetic Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-32: Cervical Spinal Synthetic Bone Graft Market, U.S., 2006 - 2016
• Figure 5-33: Trauma, Reconstruction and CMF Synthetic Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-34: Trauma Synthetic Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-35: Hip Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-36: Knee Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-37: CMF Synthetic Bone Graft Substitute Market, U.S., 2006 - 2016
• Figure 5-38: Drivers and Limiters, Bone Graft Substitute Market, U.S., 2009
• Figure 5-39: Leading Competitors, Bone Graft Substitute Market, U.S., 2009
• Figure 5-40: Leading Competitors, Standard Allograft Market, U.S., 2009
• Figure 5-41: Leading Competitors, DBM Market, U.S., 2009
• Figure 5-42: Leading Competitors, Synthetic Bone Graft Substitute Market, U.S., 2009

MACHINED BONE ALLOGRAFT MARKET

• Figure 6-1: ALIF Interbody Device Procedures by Material, U.S., 2006 - 2016
• Figure 6-2: PLIF Interbody Device Procedures by Material, U.S., 2006 - 2016
• Figure 6-3: TLIF Interbody Device Procedures by Material, U.S., 2006 - 2016
• Figure 6-4: Cervical Interbody Device Procedures by Material, U.S., 2006 - 2016
• Figure 6-5: Total Machined Bone Allograft Market, U.S., 2006 - 2016
• Figure 6-6: ALIF Machined Bone Allograft Procedures, U.S., 2006 - 2016
• Figure 6-7: ALIF Machined Bone Allograft Market, U.S., 2006 - 2016
• Figure 6-8: PLIF Machined Bone Allograft Procedures, U.S., 2006 - 2016
• Figure 6-9: PLIF Machined Bone Allograft Market, U.S., 2006 - 2016
• Figure 6-10: TLIF Machined Bone Allograft Procedures, U.S., 2006 - 2016
• Figure 6-11: TLIF Machined Bone Allograft Market, U.S., 2006 - 2016.
• Figure 6-12: Cervical Machined Bone Allograft Procedures, U.S., 2006 - 2016
• Figure 6-13: Cervical Machined Bone Allograft Market, U.S., 2006 - 2016
• Figure 6-14: Drivers and Limiters, Machined Bone Allograft Market, U.S., 2009
• Figure 6-15: Leading Competitors, Machined Bone Allograft Market, U.S., 2009

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET.

• Figure 7-1: Hyaluronic Acid Viscosupplementation J-Codes, 2009
• Figure 7-2: Total Viscosupplementation Market, U.S., 2006 - 2016
• Figure 7-3: Three-Injection Cycle Viscosupplementation Market, U.S., 2006 - 2016
• Figure 7-4: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, U.S., 2006 - 2016
• Figure 7-5: Single-Injection Cycle Viscosupplementation Market, U.S., 2009 - 2016

RESORBABLE FIXATION MARKET

• Figure 8-1: Total Resorbable Fixation Market by Segment, U.S., 2006 - 2016
• Figure 8-2: Shoulder Resorbable Fixation Market, U.S., 2006 - 2016
• Figure 8-3: ACL/PCL Reconstruction Procedures, U.S., 2006 - 2016
• Figure 8-4: Total ACL/PCL Resorbable Fixation Market, U.S., 2006 - 2016
• Figure 8-5: Total ACL/PCL Resorbable Interference Screw Market by Material, U.S., 2006 - 2016
• Figure 8-6: Standard ACL/PCL Resorbable Interference Screw Market, U.S., 2006 - 2016
• Figure 8-7: Composite ACL/PCL Resorbable Interference Screw Market, U.S., 2006 - 2016
• Figure 8-8: Resorbable ACL/PCL Cross Pin Market, U.S., 2006 - 2016
• Figure 8-9: Meniscal Resorbable Fixation Market, U.S., 2006 - 2016
• Figure 8-10: Meniscal Tack Market, U.S., 2006 - 2016
• Figure 8-11: Hybrid Tack Market, U.S., 2006 - 2016
• Figure 8-12: Drivers and Limiters, Resorbable Fixation Market, U.S., 2009
• Figure 8-13: Leading Competitors, Total Resorbable Fixation Market, U.S., 2009

TENDON GRAFT MARKET

• Figure 9-1: ACL/PCL Reconstruction Procedures, U.S., 2006 - 2016
• Figure 9-2: Total Tendon Graft Market, U.S., 2006 - 2016
• Figure 9-3: Units Procured per Donor, U.S., 2009
• Figure 9-4: Leading Competitors, Tendon Graft Market, U.S., 2009

CARTILAGE REPAIR MARKET

• Figure 10-1: Cartilage Autograft Procedures, U.S., 2006 - 2016
• Figure 10-2: Total Cartilage Repair Market, U.S., 2006 - 2016
• Figure 10-3: Autologous Chondrocyte Implantation Market, U.S., 2006 - 2016
• Figure 10-4: Osteochondral Allograft Market, U.S., 2006 - 2016
• Figure 10-5: Meniscal Graft Market, U.S., 2006 - 2016
• Figure 10-6: Drivers and Limiters, Cartilage Repair Market, U.S., 2009
• Figure 10-7: Leading Competitors, Cartilage Repair Market, U.S., 2009.

PLATELET AND BONE MARROW CONCENTRATION MARKET

• Figure 11-1: Total Platelet and Bone Marrow Concentration Market, U.S., 2006 - 2016
• Figure 11-2: Spinal Platelet Concentration Market, U.S., 2006 - 2106
• Figure 11-3: Extremity and Sports Medicine Platelet Concentration Market, U.S., 2006 - 2016
• Figure 11-4: Bone Marrow Aspirate Concentration Market, U.S., 2006 - 2016
• Figure 11-5: Drivers and Limiters, Platelet and Bone Marrow Concentration Market, U.S., 2009
• Figure 11-6: Leading Competitors, Platelet and Bone Marrow Concentration Market, U.S., 2009

ORTHOPEDIC STEM CELL MARKET

• Figure 12-1: Orthopedic Stem Cell Market, U.S., 2006 - 2016
• Figure 12-2: Lumbar Spine Stem Cell Market, U.S., 2006 - 2016
• Figure 12-3: Drivers and Limiters, Orthopedic Stem Cell Market, U.S., 2009
• Figure 12-4: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2009

EMERGING TECHNOLOGIES

ABBREVIATIONS

LIST OF CHART S

EXECUTIVE SUMMARY

• Chart 1-1: Total Orthopedic Biomaterials Market, U.S. 2009
• Chart 1-2: Orthopedic Biomaterials Market by Segment, U.S., 2006 - 2016
• Chart 1-3: Machined Bone Allograft Market, U.S., 2006 - 2016
• Chart 1-4: Single-Injection Viscosupplementation Market, U.S., 2009 - 2016
• Chart 1-5: Resorbable Shoulder Fixation Device Market, U.S., 2006 - 2016
• Chart 1-6: Tendon Allograft Unit Volumes in Relation to ACL/PCL Procedures, U.S., 2006 - 2016
• Chart 1-7: Cartilage Autograft Procedure Volumes, U.S., 2006 - 2016
• Chart 1-8: Platelet and Bone Marrow Concentration Market for Orthopedic Indications, U.S., 2007 - 2016
• Chart 1-9: Orthopedic Stem Cell Market, U.S., 2006 - 2016
• Chart 1-10: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2009

RESEARCH METHODOLOGY

OVERVIEW OF ORTHOPEDIC BIOMATERIALS.

• Chart 3-1: Total Orthopedic Biomaterials Market, U.S., 2006 - 2016
• Chart 3-2: Total Orthopedic Biomaterials Market by Segment, U.S., 2006 - 2016
• Chart 3-3: Total Orthopedic Biomaterials Market by Segment, U.S., 2009
• Chart 3-4: Total Orthopedic Biomaterials Market by Segment, U.S., 2016
• Chart 3-5: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2009
• Chart 3-6: Market Concentration, Orthopedic Biomaterials Market, U.S., 2009

GROWTH FACTOR MARKET

• Chart 4-1: Total Growth Factor Market, U.S., 2006 - 2016
• Chart 4-2: Leading Competitors, Growth Factor Market, U.S., 2009

BONE GRAFT SUBSTITUTE MARKET

• Chart 5-1: Total Bone Graft Substitute Market, U.S., 2006 - 2016
• Chart 5-2: Cervical Spinal Bone Graft Substitute Market, U.S., 2006 - 2016
• Chart 5-3: Trauma Bone Graft Substitute Market, U.S., 2006 - 2016
• Chart 5-4: Hip Bone Graft Substitute Market, U.S., 2006 - 2016
• Chart 5-5: Knee Bone Graft Substitute Market, U.S., 2006 - 2016.
• Chart 5-6: CMF Bone Graft Substitute Market, U.S., 2006 - 2016.
• Chart 5-7: Total Standard Allograft Market, U.S., 2006 - 2016
• Chart 5-8: Spinal Standard Allograft Market, U.S., 2006 - 2016
• Chart 5-9: Thoracolumbar Spinal Standard Allograft Market, U.S., 2006 - 2016
• Chart 5-10: Cervical Spinal Standard Allograft Market, U.S., 2006 - 2016
• Chart 5-11: Trauma, Reconstruction and CMF Standard Allograft Procedures, U.S., 2009
• Chart 5-12: Trauma, Reconstruction and CMF Standard Allograft Market, U.S. 2006 - 2016
• Chart 5-13: Total DBM Market, U.S., 2006 - 2016
• Chart 5-14: Spinal DBM Market, U.S., 2006 - 2016
• Chart 5-15: Thoracolumbar Spinal DBM Market, U.S., 2006 - 2016
• Chart 5-16: Cervical Spinal DBM Market, U.S., 2006 - 2016
• Chart 5-17: Trauma, Reconstruction and CMF DBM Procedures, U.S., 2009
• Chart 5-18: Trauma, Reconstruction and CMF DBM Market, U.S., 2006 - 2016
• Chart 5-19: Total Synthetic Bone Graft Substitute Market, U.S., 2006 - 2016
• Chart 5-20: Spinal Synthetic Bone Graft Substitute Market, U.S., 2006 - 2016
• Chart 5-21: Thoracolumbar Spinal Synthetic Bone Graft Substitute Market, U.S., 2006 - 2016
• Chart 5-22: Cervical Spinal Synthetic Bone Graft Market, U.S., 2006 - 2016
• Chart 5-23: Trauma, Reconstruction and CMF Synthetic Bone Graft Substitut eProcedures, U.S., 2009
• Chart 5-24: Trauma, Reconstruction and CMF Synthetic Bone Graft Substitute Market, U.S., 2006 - 2016
• Chart 5-25: Leading Competitors, Bone Graft Substitute Market, U.S., 2009
• Chart 5-26: Leading Competitors, Standard Allograft Market, U.S., 2009
• Chart 5-27: Leading Competitors, DBM Market, U.S., 2009
• Chart 5-28: Leading Competitors, Synthetic Bone Graft Substitute Market, U.S., 2009

MACHINED BONE ALLOGRAFT MARKET

• Chart 6-1: Total Machined Bone Allograft Market, U.S., 2006 - 2016
• Chart 6-2: ALIF Machined Bone Allograft Market, U.S., 2006 - 2016
• Chart 6-3: PLIF Machined Bone Allograft Market, U.S., 2006 - 2016
• Chart 6-4: TLIF Machined Bone Allograft Market, U.S., 2006 - 2016
• Chart 6-5: Cervical Machined Bone Allograft Market, U.S., 2006 - 2016
• Chart 6-6: Leading Competitors, Machined Bone Allograft Market, U.S., 2009

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET.

• Chart 7-1: Total Viscosupplementation Market, U.S., 2006 - 2016
• Chart 7-2: Three-Injection Cycle Viscosupplementation Market, U.S., 2006 - 2016
• Chart 7-3: Five-Injection Cycle Viscosupplementation Market, U.S., 2006 - 2016
• Chart 7-4: Single-Injection Cycle Viscosupplementation Market, U.S., 2009 - 2016

RESORBABLE FIXATION MARKET

• Chart 8-1: Total Resorbable Fixation Market, U.S., 2006 - 2016
• Chart 8-2: Total Resorbable Fixation Market by Segment, U.S., 2006 - 2016
• Chart 8-3: Shoulder Resorbable Fixation Market, U.S., 2006 - 2016
• Chart 8-4: Total ACL/PCL Resorbable Interference Screw Market by Material, U.S., 2006 - 2016
• Chart 8-5: Standard ACL/PCL Resorbable Interference Screw Market, U.S., 2006 - 2016
• Chart 8-6: Composite ACL/PCL Resorbable Interference Screw Market, U.S., 2006 - 2016
• Chart 8-7: Resorbable ACL/PCL Cross Pin Market, U.S., 2006 - 2016
• Chart 8-8: Meniscal Resorbable Fixation Market, U.S., 2006 - 2016
• Chart 8-9: Meniscal Tack Market, U.S., 2006 - 2016
• Chart 8-10: Hybrid Tack Market, U.S., 2006 - 2016
• Chart 8-11: Leading Competitors, Total Resorbable Fixation Market, U.S., 2009

TENDON GRAFT MARKET

• Chart 9-1: Total Tendon Graft Market, U.S., 2006 - 2016
• Chart 9-2: Units Procured per Donor, U.S., 2009
• Chart 9-3: Leading Competitors, Tendon Graft Market, U.S., 2009

CARTILAGE REPAIR MARKET

• Chart 10-1: Total Cartilage Repair Market, U.S., 2006 - 2016
• Chart 10-2: Autologous Chondrocyte Implantation Market, U.S., 2006 - 2016
• Chart 10-3: Osteochondral Allograft Market, U.S., 2006 - 2016
• Chart 10-4: Meniscal Graft Market, U.S., 2006 - 2016
• Chart 10-5: Leading Competitors, Total Cartilage Repair Market, U.S., 2009

PLATELET AND BONE MARROW CONCENTRATION MARKET

• Chart 11-1: Total Platelet and Bone Marrow Concentration Market, U.S., 2006 - 2016
• Chart 11-2: Spinal Platelet Concentration Market, U.S., 2006 - 2016
• Chart 11-3: Extremity and Sports Medicine Platelet Concentration Market, U.S., 2006 - 2016
• Chart 11-4: Bone Marrow Aspirate Concentration, U.S., 2006 - 2106
• Chart 11-5: Leading Competitors, Platelet and Bone Marrow Concentration Market, U.S., 2009

ORTHOPEDIC STEM CELL MARKET

• Chart 12-1: Orthopedic Stem Cell Market, U.S., 2006 - 2016
• Chart 12-2: Lumbar Spine Stem Cell Market, U.S., 2006 - 2016
• Chart 12-3: Cervical Spine Stem Cell Market, U.S., 2006 - 2016
• Chart 12-4: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2009

EMERGING TECHNOLOGIES

ABBREVIATIONS

相關商品

矚目市場調查報告書

全球整形外科數據庫

Global Orthopedic Procedure Volumes Database

價格 : US $ 18000

生物材料相關市場調查報告書

口腔清潔用品&牙科用消耗品市場(牙科生技材料·特殊用途產品·修復劑):目前趨勢·市場機會·全球市場預測(∼2016年)
Oral Care Products & Other Dental Consumables Market (Dental Biomaterials, Specialty Products, & Restoratives) Current Trends, Opportunities & Global Forecasts to 2016
價格 : US $ 4650
出版日期 : 2012年04月

歐洲的牙科用人工骨替代材料，牙科再生膜及再生牙科市場(21個國家):2012年
European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2012 (21 countries)
價格 : US $ 10995
出版日期 : 2012年03月

生物相容性材料的全球市場
Biocompatible Materials
價格 : US $ 4500
出版日期 : 2012年02月

iData Research Inc.發行的生物科技相關市場調查報告書

美國的創傷·組織管理市場:2012年

U.S. Market for Wound and Tissue Management 2012

價格 : US $ 6995

出版日期 : 2012年02月

美國的牙科用人工骨替代材料，牙科再生膜及再生牙科產品市場:2012年

U.S. Market for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering Products 2012

價格 : US $ 6995

出版日期 : 2012年01月

美國的整形外科用軟骨組織及運動醫學市場:2011年

U.S. Market for Orthopedic Soft Tissue Repair and Sports Medicine 2011

價格 : US $ 6995

出版日期 : 2011年11月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!